GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Modus Therapeutics Holding MODTX.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

0.17

+6.25%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Popular Bitcoin Ethereum Nvidia Apple S&P 500 Gold EUR/USD US 10Y

At a glance

Figures in SEK, from our data supplier.

FY2025

Net income

−SEK 18.5m

FY2018FY2025

Free cash flow

−SEK 18.1m

FY2018FY2025

Shareholders' equity

SEK 9.1m

FY2018FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Research and developmentSEK 10.8mSEK 9.1mSEK 8.5mSEK 10.9mSEK 13.5mSEK 3.7mSEK 36.1mSEK 41.7m
Operating income−SEK 18.2m−SEK 15.8m−SEK 16.4m−SEK 18.0m−SEK 20.7m−SEK 6.0m−SEK 43.6m−SEK 49.1m
Net income−SEK 18.5m−SEK 15.5m−SEK 17.9m−SEK 18.3m−SEK 20.7m−SEK 6.0m−SEK 43.6m−SEK 49.7m
Diluted earnings per share-0.15-0.43-0.79-1.14-1.29-0.37-0.31-0.36

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Total assetsSEK 12.7mSEK 4.9mSEK 20.0mSEK 11.3mSEK 21.2mSEK 7.5mSEK 2.1mSEK 47.0m
Cash and short-term investmentsSEK 11.4mSEK 4.4mSEK 19.1mSEK 10.4mSEK 20.6mSEK 7.3mSEK 1.4mSEK 45.8m
Total liabilitiesSEK 3.6mSEK 2.7mSEK 2.4mSEK 13.9mSEK 5.5mSEK 496,000SEK 4.7mSEK 23.0m
Debt———SEK 11.5m—SEK 26,000SEK 2.5m—
Shareholders' equitySEK 9.1mSEK 2.1mSEK 17.7m−SEK 2.6mSEK 15.7mSEK 7.0m−SEK 2.7mSEK 23.9m
Shares outstanding122m36m23m16m16m16m139m139m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash from operations−SEK 18.1m−SEK 14.7m−SEK 16.7m−SEK 21.7m−SEK 16.1m−SEK 7.2m−SEK 43.9m−SEK 40.1m
Capital spending——————−SEK 16,000−SEK 54,000
Free cash flow−SEK 18.1m−SEK 14.7m−SEK 16.7m−SEK 21.7m−SEK 16.1m−SEK 7.2m−SEK 43.9m−SEK 40.1m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Operating income−SEK 4.6m−SEK 3.3m−SEK 5.3m−SEK 4.3m−SEK 5.9m−SEK 2.7m−SEK 4.8m−SEK 3.0m
Net income−SEK 4.6m−SEK 3.3m−SEK 5.3m−SEK 4.3m−SEK 6.1m−SEK 2.8m−SEK 4.7m−SEK 3.0m
Diluted earnings per share-0.03-0.02-0.04-0.04-0.05-0.02-0.13-0.08
Cash from operations−SEK 3.0m−SEK 4.0m−SEK 5.0m−SEK 5.0m−SEK 3.0m—−SEK 3.0m−SEK 3.0m
Total assetsSEK 13.3mSEK 7.8mSEK 12.7mSEK 17.5mSEK 3.4mSEK 6.2mSEK 4.9mSEK 8.6m
Cash and short-term investmentsSEK 12.5mSEK 6.9mSEK 11.4mSEK 16.5mSEK 1.9mSEK 5.3mSEK 4.4mSEK 8.0m
Debt————SEK 5.0mSEK 5.0m——
Shareholders' equitySEK 10.2mSEK 5.8mSEK 9.1mSEK 14.5m−SEK 6.7m−SEK 678,000SEK 2.1mSEK 6.9m

Growth per year

Compound annual rate

3 years5 years10 years
Operating income0.3%24.7%—
Net income0.4%25.2%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021
Price to earnings-1.1-0.4-0.2-0.1-0.2

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.